Cabaletta Bio News

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

PHILADELPHIA, May 29, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapi

GlobeNewswireMay 29 08:00 ET

We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after l

Simply Wall StMay 24 11:37 ET

H.C. Wainwright Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $30

H.C. Wainwright analyst Douglas Tsao maintains $Cabaletta Bio(CABA.US)$ with a buy rating, and maintains the target price at $30.According to TipRanks data, the analyst has a success rate of 37.0% and

moomoo NewsMay 24 06:32 ET

We Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth

Yahoo FinanceMay 22 15:21 ET

Express News | HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $30 Price Target

BenzingaMay 16 07:54 ET

Cabaletta Bio Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 136.41% HC Wainwright & Co. → $30 Reiterates Buy → Buy 04/05/2024 294.01% Cantor Fitzgerald → $

BenzingaMay 16 07:53 ET

Express News | Cabaletta Bio Inc : Jefferies Cuts Target Price to $31 From $36

ReutersMay 16 00:29 ET

Cabaletta Bio's Promising Clinical Advancements and Stable Financial Outlook Merit a Buy Rating

TipRanksMay 15 13:45 ET

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.Bolt Biotherapeutics posted a GAAP loss of 28 cent

BenzingaMay 15 13:38 ET

William Blair Reaffirms Their Buy Rating on Cabaletta Bio (CABA)

TipRanksMay 15 12:46 ET

NEXTracker Posts Upbeat Earnings, Joins Monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Dow Jones gaining around 150 points on Wednesday.Shares of Nextracker Inc. (NASDAQ:NXT) rose sharply during Wednesday's session after the company reported better-than

BenzingaMay 15 10:21 ET

Cabaletta Bio | 10-Q: Quarterly report

SEC announcementMay 15 07:55 ET · Announcements

Cabaletta Bio Reveals Insights in Updated Corporate Presentation

TipRanksMay 15 07:22 ET

Express News | Cabaletta Bio Expects That Its Cash, Cash Equivalents And Short-term Investments Of $223.8M As Of March 31, 2024, Will Enable It To Fund Its Operating Plan Into The First Half Of 2026

BenzingaMay 15 07:12 ET

Express News | Cabaletta Bio Q1 2024 GAAP EPS $(0.51) Misses $(0.47) Estimate

BenzingaMay 15 07:11 ET

Cabaletta Bio Had Cash, Cash Equivalents and Short-Term Investments of $223.8M at March 31 >CABA

Cabaletta Bio Had Cash, Cash Equivalents and Short-Term Investments of $223.8M at March 31 >CABA

Dow JonesMay 15 07:03 ET

Express News | Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

ReutersMay 15 07:00 ET

Express News | Cabaletta Bio Q1 Operating Expenses USD 28.031 Million

ReutersMay 15 07:00 ET

Express News | Cabaletta Bio Q1 Income From Operations USD -28.031 Million

ReutersMay 15 07:00 ET

Press Release: Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update -- No CRS or ICANS of any grade observed during the 28-day DLT observation window for either of the first patie

Dow JonesMay 15 07:00 ET